TABLE 2.
Multivariate Analysis for Predictors of PVT at Transplantation
| OR | 95% CI | P Value | |
|---|---|---|---|
| NASH cirrhosis | 1.55 | 1.33–1.81 | <0.001 |
| HCV | 0.91 | 0.82–1.00 | 0.058 |
| Cholestatic disease | 0.87 | 0.73–1.03 | 0.10 |
| Sex, male | 1.08 | 0.98–1.19 | 0.11 |
| African American | 0.76 | 0.64–0.90 | <0.001 |
| race | |||
| Age, years | 1.01 | 1.00–1.02 | <0.001 |
| Final MELD score | 1.01 | 1.00–1.01 | 0.04 |
| BMI, kg/m2 | 1.00 | 0.99–1.01 | 0.10 |
| Ascites > 2 | 1.11 | 1.00–1.23 | 0.05 |
| Encephalopathy > 2 | 0.98 | 0.85–1.14 | 0.82 |
| Final INR | 1.00 | 0.95–1.05 | 0.96 |
NOTE: An OR >1.0 indicates a relative risk for development of PVT, whereas an OR < 1.0 indicates protection from development of PVT.